Continuous intra-arterial nimodipine for the treatment of cerebral vasospasm

Cardiovasc Intervent Radiol. 2008 Nov-Dec;31(6):1200-4. doi: 10.1007/s00270-008-9346-0. Epub 2008 Apr 30.

Abstract

Two patients with refractory symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH) were treated by continuous intra-arterial nimodipine infusion via a catheter placed in the internal carotid artery or vertebral artery for 3 and 12 days, respectively. Recovery of the neurological deficits, normalization of MR perfusion, a decrease in the elevated mean flow velocity measured by transcranial duplex sonography, and angiographic recanalization were observed. Continuous intra-arterial nimodipine might be a treatment option in severe refractory vasospasm following SAH.

Publication types

  • Case Reports

MeSH terms

  • Angiography, Digital Subtraction
  • Cerebral Angiography
  • Female
  • Humans
  • Infusions, Intra-Arterial
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Nimodipine / administration & dosage
  • Nimodipine / therapeutic use*
  • Treatment Outcome
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use*
  • Vasospasm, Intracranial / diagnosis
  • Vasospasm, Intracranial / diagnostic imaging
  • Vasospasm, Intracranial / drug therapy*

Substances

  • Vasodilator Agents
  • Nimodipine